title: Integrin alpha 6 regulates glioblastoma stem cells.
abstract: Cancer stem cells (CSCs) are a subpopulation of tumor cells suggested to be critical for tumor maintenance, metastasis, and therapeutic resistance. Prospective identification and targeting of CSCs are therefore priorities for the development of novel therapeutic paradigms. Although CSC enrichment has been achieved with cell surface proteins including CD133 (Prominin-1), the roles of current CSC markers in tumor maintenance remain unclear. We examined the glioblastoma stem cell (GSC) perivascular microenvironment in patient specimens to identify enrichment markers with a functional significance and identified integrin alpha6 as a candidate. Integrin alpha6 is coexpressed with conventional GSC markers and enriches for GSCs. Targeting integrin alpha6 in GSCs inhibits self-renewal, proliferation, and tumor formation capacity. Our results provide evidence that GSCs express high levels of integrin alpha6, which can serve not only as an enrichment marker but also as a promising antiglioblastoma therapy.
authors.affiliation: Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
authors.forename: Justin D
authors.initials: JD
authors.lastname: Lathia
authors.forename: Joseph
authors.initials: J
authors.lastname: Gallagher
authors.forename: John M
authors.initials: JM
authors.lastname: Heddleston
authors.forename: Jialiang
authors.initials: J
authors.lastname: Wang
authors.forename: Christine E
authors.initials: CE
authors.lastname: Eyler
authors.forename: Jennifer
authors.initials: J
authors.lastname: Macswords
authors.forename: Qiulian
authors.initials: Q
authors.lastname: Wu
authors.forename: Amit
authors.initials: A
authors.lastname: Vasanji
authors.forename: Roger E
authors.initials: RE
authors.lastname: McLendon
authors.forename: Anita B
authors.initials: AB
authors.lastname: Hjelmeland
authors.forename: Jeremy N
authors.initials: JN
authors.lastname: Rich
mesh_terms: D000071916:AC133 Antigen; D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D015703:Antigens, CD / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D055785:Gene Knockdown Techniques; D005909:Glioblastoma / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D039503:Integrin alpha6 / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D010455:Peptides / Q000378:metabolism; D010641:Phenotype
chemical_list: D000071916:AC133 Antigen; D019138:Antibodies, Blocking; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D039503:Integrin alpha6; C000606023:PROM1 protein, human; D010455:Peptides; C000606024:Prom1 protein, mouse
references.citation: Oncogene. 2009 Apr 16;28(15):1807-11
references.pmid: 19287454
references.citation: J Neurosci Res. 1992 Aug;32(4):494-506
references.pmid: 1356158
references.citation: Stem Cells. 2007 Oct;25(10):2524-33
references.pmid: 17628016
references.citation: Cancer Cell. 2007 Jan;11(1):69-82
references.pmid: 17222791
references.citation: Cancer Res. 2008 Oct 1;68(19):7882-6
references.pmid: 18829544
references.citation: Lab Invest. 2008 Aug;88(8):808-15
references.pmid: 18560366
references.citation: Cancer Cell. 2009 Feb 3;15(2):135-47
references.pmid: 19185848
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
references.pmid: 14645703
references.citation: PLoS Biol. 2009 Aug;7(8):e1000176
references.pmid: 19688041
references.citation: Nature. 2006 Dec 7;444(7120):756-60
references.pmid: 17051156
references.citation: Histopathology. 1996 Jun;28(6):521-8
references.pmid: 8803595
references.citation: Neuron. 2001 Aug 16;31(3):367-79
references.pmid: 11516395
references.citation: J Clin Oncol. 2008 Dec 1;26(34):5610-7
references.pmid: 18981465
references.citation: Cell Stem Cell. 2009 Aug 7;5(2):168-77
references.pmid: 19664991
references.citation: Stem Cells. 2007 Sep;25(9):2146-57
references.pmid: 17569787
references.citation: Cancer Cell. 2005 Oct;8(4):323-35
references.pmid: 16226707
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
references.pmid: 11121071
references.citation: J Neurosci Methods. 2009 Jan 30;176(2):192-9
references.pmid: 19215724
references.citation: Cancer Cell. 2006 May;9(5):391-403
references.pmid: 16697959
references.citation: Cancer Cell. 2009 Jun 2;15(6):501-13
references.pmid: 19477429
references.citation: Nature. 2006 Dec 7;444(7120):761-5
references.pmid: 17151667
references.citation: Cancer Res. 2006 Aug 1;66(15):7445-52
references.pmid: 16885340
references.citation: Cancer Res. 2003 Sep 15;63(18):5821-8
references.pmid: 14522905
references.citation: Cell Stem Cell. 2009 May 8;4(5):440-52
references.pmid: 19427293
references.citation: Nature. 2008 Oct 23;455(7216):1129-33
references.pmid: 18948956
references.citation: Cancer Res. 2008 Aug 1;68(15):6043-8
references.pmid: 18676824
references.citation: Nature. 2004 Nov 18;432(7015):396-401
references.pmid: 15549107
references.citation: BMC Neurosci. 2008 Jul 23;9:71
references.pmid: 18651950
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Cell Stem Cell. 2009 Jun 5;4(6):568-80
references.pmid: 19497285
references.citation: J Biol Chem. 2006 Dec 29;281(52):40450-60
references.pmid: 17085437
references.citation: PLoS One. 2008;3(11):e3769
references.pmid: 19020659
references.citation: Oncogene. 2004 Dec 16;23(58):9392-400
references.pmid: 15558011
references.citation: Cancer Res. 2007 May 1;67(9):4010-5
references.pmid: 17483311
references.citation: Development. 2004 Jul;131(14):3433-44
references.pmid: 15226259
references.citation: Cancer Res. 2006 Aug 15;66(16):7843-8
references.pmid: 16912155
references.citation: Cancer Res. 2008 Oct 1;68(19):7711-7
references.pmid: 18829523
references.citation: Curr Biol. 1998 Aug 27;8(17):983-6
references.pmid: 9742403
references.citation: Cereb Cortex. 2003 Mar;13(3):219-24
references.pmid: 12571112
references.citation: Dev Dyn. 2007 Dec;236(12):3267-82
references.pmid: 17937403
references.citation: Am J Pathol. 1993 Jul;143(1):154-63
references.pmid: 8317546
references.citation: Cell. 2002 Sep 20;110(6):673-87
references.pmid: 12297042
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Nat Rev Cancer. 2007 Oct;7(10):733-6
references.pmid: 17882276
references.citation: Int J Cancer. 2008 Feb 15;122(4):761-8
references.pmid: 17955491
references.citation: Stem Cells. 2006 Sep;24(9):2078-84
references.pmid: 16690778
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Mol Cancer. 2006 Dec 02;5:67
references.pmid: 17140455
references.citation: J Comp Neurol. 2007 Dec 20;505(6):630-43
references.pmid: 17948866
references.citation: J Neuroimmunol. 1995 Mar;57(1-2):143-53
references.pmid: 7535788
references.citation: Cancer Res. 2007 Jul 15;67(14):6796-805
references.pmid: 17638891
references.citation: Cancer Res. 2004 Oct 1;64(19):7011-21
references.pmid: 15466194
references.citation: Stem Cells. 2008 Dec;26(12):3027-36
references.pmid: 18802038
references.citation: Glia. 2002 Sep;39(3):193-206
references.pmid: 12203386
references.citation: Neurosurgery. 2008 Feb;62(2):505-14; discussion 514-5
references.pmid: 18382330
references.citation: J Mol Med (Berl). 2008 Sep;86(9):1025-32
references.pmid: 18535813
references.citation: Stem Cells. 2008 Jun;26(6):1414-24
references.pmid: 18403755
references.citation: Science. 2003 Oct 17;302(5644):393; author reply 393
references.pmid: 14563990
references.citation: Cell Stem Cell. 2008 Sep 11;3(3):289-300
references.pmid: 18786416